Why the study?
Is VLDLR gene polymorphism associated with severe carotid artery disease, BMI, and lipid traits, and does it interact with APOE genotype?
Is VLDLR gene polymorphism associated with severe carotid artery disease, BMI, and lipid traits, and does it interact with APOE genotype?
A common VLDLR polymorphism (rs1454626) and its interaction with the APOE genotype are associated with severe carotid artery disease, BMI, and lipid traits.
Does not support clinical genetic testing; leaves open VLDLR-APOE interactions in CAAD risk prediction.
The genetic factors associated with carotid artery disease (CAAD) are not fully known. Because of its role in lipid metabolism, we hypothesized that common genetic variation in the very low density lipoprotein receptor (VLDLR) gene is associated with severe CAAD (>80% stenosis), body mass index (BMI), and lipid traits in humans. VLDLR was resequenced for variation discovery in 92 subjects, and single nucleotide polymorphisms (tagSNPs) were chosen for genotyping in a larger cohort (n = 1,027). Of the 17 tagSNPs genotyped, one tagSNP (SNP 1226; rs1454626) located in the 5' flanking region of VLDLR was associated with CAAD, BMI, and LDL-associated apolipoprotein B (apoB). We also identified receptor-ligand genetic interactions between VLDLR 1226 and APOE genotype for predicting CAAD case status. These findings may further our understanding of VLDLR function, its ligand APOE, and ultimately the pathogenesis of CAAD in the general population.
No takes yet. Share an insight, caveat, or question.
Crawford et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: